| Autor: |
Henriksen PA; British Heart Foundation Centre for Cardiovascular Science (P.A.H.), University of Edinburgh, UK., Hall P; Cancer Research UK - Edinburgh Centre (P.H.), University of Edinburgh, UK.; Medical Research Council Institute Genetics and Molecular Medicine (P.H.), University of Edinburgh, UK., Lang NN; School of Cardiovascular and Metabolic Health, University of Glasgow, UK (N.N.L.). |
| Jazyk: |
angličtina |
| Zdroj: |
Circulation [Circulation] 2024 May 28; Vol. 149 (22), pp. e1221-e1222. Date of Electronic Publication: 2024 May 28. |
| DOI: |
10.1161/CIRCULATIONAHA.124.069375 |
| Abstrakt: |
Competing Interests: Disclosures Dr Lang reports research grants from Roche Diagnostics, Astra Zeneca, and Boehringer Ingelheim, as well as consultancy or speaker’s fees from Boehringer Ingelheim, Roche Diagnostics, Myokardia, Pharmacosmos, Akero Therapeutics, CV6 Therapeutics, Jazz Pharma, and Novartis, all outside the submitted work. The other authors report no conflicts. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
